About
Vor Biopharma Inc (NASDAQ:VOR) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 30 2026
Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Mar 30 2026
Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren’s Disease
Mar 27 2026
Vor Bio Announces $75 Million Private Placement with TCGX
Feb 23 2026
Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference
Jan 6 2026
Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Financials
Revenue
$0
Market Cap
$881.7 M
EPS
-70.50
Translate